📰 Tim Chataway News
Tim Chataway News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tim Chataway. Real-time updates on events, politics, business and more.
May 16, 2024
<p>New research led by Flinders University and international experts is expanding understanding of vaccine-induced immune thrombocytopenia and thrombosis (known as VITT).</p> <p>&nbsp;</p> <p>At the height of the COVID-19 pandemic in 2021,VITT emerged as a new disease following adenovirus vector-based vaccines &ndash; notably the Oxford-AstraZeneca vaccine.</p>
January 27, 2023
Researchers used sequential doses of boiled peanuts followed by roasted peanuts to desensitize children to peanut allergy.
January 12, 2023
Every single bite is a potential source of worry for seven-year-old Oliver Clark, who suffers from a peanut...
January 13, 2022
The discovery and validation of potential disease progression biomarkers has been one of the top priorities in ALS/MND research. An international
January 13, 2022
An international collaboration led by Flinders University has identified a potential biomarker for amyotrophic lateral sclerosis, also known as Motor Neuron Disease, providing a way to test the effectiveness of future clinical trials.
February 19, 2021
Date Time Positive signs of immunity after COVID-19 infection Australian scientists have described the evolution of immunity levels up to four months following COVID-19 infection, finding that while antibody levels drop dramatically in the first one to two months, the decrease then slows down substantially. The findings suggest that protective COVID-19 vaccines should ideally generate stronger antibody responses than natural infection. The research, led by Professor Stephen Kent from the Dohert...